Editas Medicine, Inc. (EDIT) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Editas Medicine, Inc.
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy…
Source: Yahoo Finance
Sector & Industry
Editas Medicine, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Editas Medicine, Inc. at a Glance
| Company | Editas Medicine, Inc. |
| Ticker | EDIT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $3.23 |
| Market cap | $496.06M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.66 |
| 52-week high | $4.54 |
| 52-week low | $1.66 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.09 |
| Return on equity (ROE) | -118.82% |
| Debt-to-equity | 14.73% |
| Average volume | 2.33M |
| Shares outstanding | 153.58M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 87 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Editas Medicine, Inc.'s current P/E ratio?
- Editas Medicine, Inc. (EDIT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Editas Medicine, Inc.'s market capitalisation?
- Editas Medicine, Inc.'s market cap is $496.06M based on our latest snapshot. See how it ranks by market cap →
- What is EDIT's 52-week range?
- Over the past 52 weeks, EDIT has traded between $1.66 and $4.54. What does the 52-week range mean? →
- How volatile is Editas Medicine, Inc. compared to the market?
- Editas Medicine, Inc. has a beta of 2.09, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Editas Medicine, Inc. pay a dividend?
- Editas Medicine, Inc. does not currently pay a dividend according to our latest data.
- What exchange is EDIT listed on?
- EDIT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Editas Medicine, Inc. in?
- Editas Medicine, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →